Running summarizing tools on a new article
Check the paper below, then start its synthesis.
Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
Yong Jia (Genomics Institute of the Novartis Research Foundation), Cai‐Hong Yun (Harvard University, Dana-Farber Cancer Institute), Eunyoung Park (Harvard University, Dana-Farber Cancer Institute), Dalia Ercan (Dana-Farber Cancer Institute), Mari Manuia (Genomics Institute of the Novartis Research Foundation), Jose Juarez (Genomics Institute of the Novartis Research Foundation), Chunxiao Xu (Dana-Farber Cancer Institute), Kevin Rhee (Dana-Farber Cancer Institute), Ting Chen (Dana-Farber Cancer Institute), Haikuo Zhang (Dana-Farber Cancer Institute), Sangeetha S. Palakurthi (Dana-Farber Cancer Institute), Jaebong Jang (Harvard University, Dana-Farber Cancer Institute), G. Lelais (Genomics Institute of the Novartis Research Foundation), Michael DiDonato (Genomics Institute of the Novartis Research Foundation), Badry D. Bursulaya (Genomics Institute of the Novartis Research Foundation), Pierre‐Yves Michellys (Genomics Institute of the Novartis Research Foundation), Robert Epple (Genomics Institute of the Novartis Research Foundation), Thomas H. Marsilje (Genomics Institute of the Novartis Research Foundation), Matthew McNeill (Genomics Institute of the Novartis Research Foundation), Wenshuo Lu (Genomics Institute of the Novartis Research Foundation), Jennifer Harris (Genomics Institute of the Novartis Research Foundation), Steven L. Bender (Genomics Institute of the Novartis Research Foundation), Kwok‐Kin Wong (Dana-Farber Cancer Institute), Pasi Antero Janne (Dana-Farber Cancer Institute), Michael J. Eck (Harvard University, Dana-Farber Cancer Institute)